Corrigendum: Breakthroughs in hereditary angioedema management: a systematic review of approved drugs and those under research

Corrigendum: Breakthroughs in hereditary angioedema management: a systematic review of approved drugs and those under research

The authors wish to make corrections to their article: Nicola S, Rolla G, Brussino L. Breakthroughs in hereditary angioedema management: a systematic review of approved drugs and those under research. Drugs in Context 2019; 8: 212605. DOI: 10.7573/dic.212605

Bibliographic Details
Main Authors: Stefania Nicola, Giovanni Rolla, Luisa Brussino
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2019-12-01
Series:Drugs in Context
Subjects:
c1-inh
c1-inhibitor
gene therapy
hae
hereditary angioedema
lanadelumab
serine protease
serping1
Online Access:https://www.drugsincontext.com/corrigendum-breakthroughs-in-hereditary-angioedema-management-a-systematic-review-of-approved-drugs-and-those-under-research/

Internet

https://www.drugsincontext.com/corrigendum-breakthroughs-in-hereditary-angioedema-management-a-systematic-review-of-approved-drugs-and-those-under-research/

Similar Items